A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 4, 2007, Pages 745-749

  Goldfarb, David S ^a,b   Modersitzki, Frank ^a   Asplin, John R ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; OXALIC ACID DERIVATIVE;

ARTICLE; BIFIDOBACTERIUM; BIOLOGICAL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPEROXALURIA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; MALE; MIDDLE AGED; NEPHROLITHIASIS; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; URINE;

BIFIDOBACTERIUM; BIOLOGICAL THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPEROXALURIA; KIDNEY CALCULI; LACTIC ACID; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BREVIS; MALE; MIDDLE AGED; OXALATES; STREPTOCOCCUS THERMOPHILUS;

EID: 34548824862     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00600207     Document Type: Article

References (13)

1. Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP: Hyperoxaluria in patients with recurrent calcium oxalate calculi: Dietary and other risk factors. Br J Urol 68: 454-458, 1991
2. Yagisawa T, Chandhoke PS, Fan J: Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161: 1449-1452, 1999
3. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C: Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60: 1097-1105, 2001
4. Lieske JC, Goldfarb DS, De SC, Regnier C: Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68: 1244-1249, 2005
5. Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL: Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56: 1505-1516, 1999
6. Finlayson B: Calcium stones: Some physical and clinical aspects. In: Calcium Metabolism in Renal Failure and Nephrolithiasis, edited by David DS, New York, John Wiley and Sons, 1977, pp 337-382
7. Lieske JC, Toback FG: Interaction of urinary crystals with renal epithelial cells in the pathogenesis of nephrolithiasis. Semin Nephrol 16: 458-473, 1996
8. Anantharam V, Allison MJ, Maloney PC: Oxalate:formate exchange. The basis for energy coupling in Oxalobacter. J Biol Chem 264: 7244-7250, 1989
9. Baetz AL, Allison MJ: Purification and characterization of oxalyl-coenzyme A decarboxylase from Oxalobacter formigenes. J Bacteriol 171: 2605-2608, 1989
10. Federici F, Vitali B, Gotti R, Pasca MR, Gobbi S, Peck AB, Brigidi P: Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis. Appl Environ Microbiol 70: 5066-5073, 2004
11. Azcarate-Peril MA, Bruno-Barcena JM, Hassan HM, Klaenhammer TR: Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. Appl Environ Microbiol 72: 1891-1899, 2006
12. Daniel SL, Cox R: Oxalate consumption by probiotic microorganisms [Abstract]. Gen Meet Am Soc Microbiol, I-048, 2006
13. Weese JS, Weese HE, Yuricek L, Rousseau J: Oxalate degradation by intestinal lactic acid bacteria in dogs and cats. Vet Microbiol 101: 161-166, 2004